Last updated on August 2017

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis


Brief description of study

A Phase 2, Randomized, Dose-Ranging, Vehicle-Controlled and Triamcinolone 0.1% Cream–Controlled Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Detailed Study Description

The purpose of this study is to evaluate the efficacy of each strength of INCB018424 cream once daily or twice daily in subjects with atopic dermatitis compared with vehicle cream.

Clinical Study Identifier: TX151810

Find a site near you

Start Over

CENTER FOR CLINICAL STUDIES

Located in: Webster, TX USA
  Connect »

DERMRESEARCH

Located in: Louisville, KY USA
  Connect »

DERMRESEARCHCENTER OF NEW YORK, INC

Located in: Stony Brook, NY USA
  Connect »

HASSMAN RESEARCH INSTITUTE

Located in: BERLIN, NJ USA
  Connect »

DS RESEARCH

Located in: New Albany, IN USA
  Connect »